RecruitingNCT05224297

Patient Experience Data in Radiation Oncology


Sponsor

Medical University of Vienna

Enrollment

6,000 participants

Start Date

Oct 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

The project is part of the overarching goal of improving patient-centric radiation oncology. This pilot project aims to develop an instrument that can be used to collect clinically relevant patient-reported outcome data on adverse effects during and after RT. This real-world evidence (RWE) database will be the basis to monitor and evaluate future technological developments, combination treatments (e.g. radioimmunotherapy, etc.), or changes in treatment protocols. The pseudonymized data will be linked to data in the oncological information system and dosimetric data from the treatment planning system. In this way, they represent a basic building block of patient-oriented development of clinical radiotherapy.


Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria1

  • all patients receiving external beam radiotherapy

Exclusion Criteria1

  • unable to independently answer questionnaires on radiation-induced side effects

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONexternal beam photon therapy

Patients receive external beam photon therapy for different tumor locations (groups).


Locations(1)

Medical University of Vienna

Vienna, Vienna, Austria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05224297


Related Trials